Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid-Reference-Cited by-同舟云学术

Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid

Published:1993-03 Issue:3 Volume:39 Page:179-186
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Aurelius E.,Johansson B.,Sköldenberg B.,Forsgren M.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference43 articles.

1. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

2. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid

3. Primary and Recurrent Herpes Simplex Virus Type 2-Induced Meningitis

4. (1991): Neuropathogenecity of herpes simplex virus. Thesis, University of Gothenburg, Gothenburg, Sweden.

5. Mapping of Herpes Simplex Virus-1 Neurovirulence to γ 1 34.5, a Gene Nonessential for Growth in Culture

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LC–MS metabolomics and lipidomics in cerebrospinal fluid from viral and bacterial CNS infections: a review;Frontiers in Neurology;2024-08-05

2. Imaging in Coma and Brain Death;Coma and Brain Death - Facts, Myths and Mysteries [Working Title];2024-05-29

3. Are glucocorticoids truly effective in improving the clinical prognosis of HSV-1 encephalitis?;2024-03-22

4. Diagnostic Methods and Management Strategies of Herpes Simplex and Herpes Zoster Infections;Clinics in Geriatric Medicine;2024-02

5. Design and Synthesis of Novel 5-((3-(Trifluoromethyl)piperidin-1-yl)sulfonyl)indoline-2,3-dione Derivatives as Promising Antiviral Agents: In Vitro, In Silico, and Structure–Activity Relationship Studies;Pharmaceuticals;2023-09-04